Cargando…
Affinity of anti-spike antibodies to three major SARS-CoV-2 variants in recipients of three major vaccines
BACKGROUND: Measuring anti-viral antibody affinity in blood plasma or serum is a rational quantitative approach to assess humoral immune response and acquired protection. Three common vaccines against SARS-CoV-2—Comirnaty developed by Pfizer/BioNTech, Spikevax developed by Moderna/NIAID, and Jcovden...
Autores principales: | Macdonald, Patrick J., Schaub, Jeffrey M., Ruan, Qiaoqiao, Williams, Carroll L., Prostko, John C., Tetin, Sergey Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9403978/ https://www.ncbi.nlm.nih.gov/pubmed/36034646 http://dx.doi.org/10.1038/s43856-022-00174-9 |
Ejemplares similares
-
Method for direct measuring antibody affinity in biological sample
por: Ruan, Qiaoqiao, et al.
Publicado: (2023) -
Affinity of anti-spike antibodies in SARS-CoV-2 patient plasma and its effect on COVID-19 antibody assays
por: Macdonald, Patrick J., et al.
Publicado: (2021) -
Determining the affinity of anti-SARS-CoV-2 antibody directly in biological samples and the influence of affinity on quantitative antibody assays
por: Macdonald, Patrick J., et al.
Publicado: (2022) -
A population-based study of the three major variants of papillary
thyroid carcinoma
por: Xu, Junming, et al.
Publicado: (2021) -
The three major axes of terrestrial ecosystem function
por: Migliavacca, Mirco, et al.
Publicado: (2021)